10440 related articles for article (PubMed ID: 14522636)
1. The role of light in the treatment of non-melanoma skin cancer using methyl aminolevulinate.
Brown SB
J Dermatolog Treat; 2003; 14 Suppl 3():11-4. PubMed ID: 14522636
[TBL] [Abstract][Full Text] [Related]
2. Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls.
Morton CA
J Dermatolog Treat; 2003; 14 Suppl 3():23-6. PubMed ID: 14522638
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy.
Foley P
J Dermatolog Treat; 2003; 14 Suppl 3():15-22. PubMed ID: 14522637
[TBL] [Abstract][Full Text] [Related]
4. MAL-PDT for difficult to treat nonmelanoma skin cancer.
Stebbins WG; Hanke CW
Dermatol Ther; 2011; 24(1):82-93. PubMed ID: 21276161
[TBL] [Abstract][Full Text] [Related]
5. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
6. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196
[TBL] [Abstract][Full Text] [Related]
8. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
[TBL] [Abstract][Full Text] [Related]
9. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
Lesar A; Ferguson J; Moseley H
Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897
[TBL] [Abstract][Full Text] [Related]
10. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Tyrrell JS; Campbell SM; Curnow A
Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
[TBL] [Abstract][Full Text] [Related]
11. Short incubation fractional CO
Vrani F; Sotiriou E; Lazaridou E; Vakirlis E; Sideris N; Kirmanidou E; Apalla Z; Lallas A; Ioannides D
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):79-83. PubMed ID: 29869444
[TBL] [Abstract][Full Text] [Related]
12. The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
Blake E; Campbell S; Allen J; Mathew J; Helliwell P; Curnow A
J Photochem Photobiol B; 2012 Dec; 117():97-103. PubMed ID: 23092624
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions.
Themstrup L; Banzhaf CA; Mogensen M; Jemec GB
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):7-12. PubMed ID: 24280439
[TBL] [Abstract][Full Text] [Related]
14. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
Ibbotson SH; Valentine R; Hearn R
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
[TBL] [Abstract][Full Text] [Related]
15. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274
[TBL] [Abstract][Full Text] [Related]
16. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers.
Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041
[TBL] [Abstract][Full Text] [Related]
17. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate.
Angell-Petersen E; Sørensen R; Warloe T; Soler AM; Moan J; Peng Q; Giercksky KE
J Invest Dermatol; 2006 Feb; 126(2):265-71. PubMed ID: 16374471
[TBL] [Abstract][Full Text] [Related]
18. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy for non-melanoma skin cancer.
Fien SM; Oseroff AR
J Natl Compr Canc Netw; 2007 May; 5(5):531-40. PubMed ID: 17509255
[TBL] [Abstract][Full Text] [Related]
20. Topical methyl aminolevulinate.
Siddiqui MA; Perry CM; Scott LJ
Am J Clin Dermatol; 2004; 5(2):127-37; discussion 138-40. PubMed ID: 15109276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]